Context Therapeutics CNTX
NASDAQ CNTX
$0.24 0.00 (-1.88%)
As of: Oct 21, 2026 · 10:28 AM EDT

Context Therapeutics (CNTX) Debt Ratio (2020)

Updated

Context Therapeutics' Debt Ratio was 12.74 in Q4 2020.

Analysis

Context Therapeutics (CNTX) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn 0.39
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn 0.24
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn 0.52
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 0.42
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn 0.08
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 0.28
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn 0.53
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn 0.31
10 Context Therapeutics 22.42 Mn -218.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 12.74
API Access

Context Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CNTX&period=max&api_key=YOUR_API_KEY